Selected strength:0.5mg
Selected Pack Size:1.5 ml
(₹9233.33 / 1 ml)
In Stock
MRP ₹13850
(Inclusive of all Taxes)
₹2077.5 Cashback (15%)
Provide Delivery Location
About Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml
Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml is used for chronic weight management in adults. It is prescribed alongside a reduced-calorie diet and increased physical activity to help achieve and maintain weight loss in patients with obesity or those who have weight-related health conditions.
Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone involved in appetite regulation. It works by slowing down gastric emptying, increasing the feeling of fullness, and reducing food cravings, which helps lower overall calorie intake.
In some cases, Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml may cause side effects such as nausea, vomiting, diarrhoea, constipation, abdominal discomfort, dizziness, or altered taste. Talk to your doctor if the side effects persist or worsen.
Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml should also not be used during pregnancy, while breastfeeding, or in children under 12 years of age. The pen contains 4 doses, designed to provide coverage for an entire month since it is administered once weekly.
Uses of Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml
Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml is used to treat various medical conditions. The detailed uses are as follows:

Have a query?
Directions for Use
Medicinal Benefits
How Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml Works
Storage
What if I have taken an overdose of Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml
Drug Warnings
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
RXNovo Nordisk India Pvt Ltd
₹10170
(₹6780.0/ 1ml)
Alcohol
Caution
You are recommended to avoid alcohol consumption while taking Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml. It could lead to increased adverse events.
Pregnancy
Unsafe
Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml should not be used during pregnancy as there is a potential risk of harm to the unborn baby. Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml is not recommended for women who are pregnant, planning to conceive soon, or not using reliable contraception during therapy.
Breast Feeding
Unsafe
Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml is not recommended during breastfeeding as its safety is not established.
Driving
Caution
Generally does not impair ability to drive; however, dizziness or low blood sugar (if combined with other drugs) may affect alertness.
Liver
Caution
Inform your doctor before receiving Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml if you have a pre-existing or a history of liver disease. Your doctor will prescribe only if the benefits outweigh the risks.
Kidney
Caution
Inform your doctor before receiving Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml if you have a pre-existing or a history of kidney disease. Your doctor will prescribe only if the benefits outweigh the risks.
Children
Unsafe
Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml is not recommended for children as efficacy and safety have not been established.
Heart
Consult your doctor
Inform your doctor if you have any heart problems before using Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml.
Geriatrics
Caution
Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml should be used with caution in elderly patients, as it may be associated with a higher risk of fractures.
Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml is used for long-term weight management in adults with obesity or overweight with related medical conditions and to reduce cardiovascular risks.
Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml works by mimicking the GLP-1 hormone, which increases satiety, reduces hunger, and slows digestion, leading to lower calorie intake and weight loss.
The most common side effects include nausea, vomiting, diarrhoea, constipation, abdominal discomfort, and dizziness, usually improving over time.
No, it should not be used during pregnancy or breastfeeding. It must be stopped at least 2 months before planning pregnancy.
Wegovy Flextouch 0.5 mg PFP Combipack Injection 1.5 ml should not be taken with other GLP-1 receptor agonists or weight-loss products unless specifically advised by your doctor.
There are no strict dietary restrictions, but alcohol should be limited as it may worsen gastrointestinal symptoms or increase hypoglycemia risk.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.Prepaid payment required.
We provide you with authentic, trustworthy and relevant information